These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23617835)

  • 1. An analysis of the economic impact of smoking cessation in Europe.
    Cohen D; Alam MF; Jarvis PS
    BMC Public Health; 2013 Apr; 13():390. PubMed ID: 23617835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling a budgetary impact analysis for funding drug-based smoking cessation therapies for patients with major depressive disorder in Spain.
    Rejas-Gutiérrez J; Bruguera E; Cedillo S
    Eur Psychiatry; 2017 Sep; 45():41-49. PubMed ID: 28728094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Impact of Financial Incentives and Mailing Nicotine Patches to Help Medicaid Smokers Quit Smoking: A Cost-Benefit Analysis.
    Sung HY; Penko J; Cummins SE; Max W; Zhu SH; Bibbins-Domingo K; Kohatsu ND
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S148-S158. PubMed ID: 30454669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial.
    Japuntich SJ; Regan S; Viana J; Tymoszczuk J; Reyen M; Levy DE; Singer DE; Park ER; Chang Y; Rigotti NA
    Trials; 2012 Aug; 13():124. PubMed ID: 22852832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
    Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
    Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of the English smoking treatment services: evidence from practice.
    Godfrey C; Parrott S; Coleman T; Pound E
    Addiction; 2005 Apr; 100 Suppl 2():70-83. PubMed ID: 15844290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricting tobacco sales to only pharmacies combined with cessation advice: a modelling study of the future smoking prevalence, health and cost impacts.
    Petrović-van der Deen FS; Blakely T; Kvizhinadze G; Cleghorn CL; Cobiac LJ; Wilson N
    Tob Control; 2019 Nov; 28(6):643-650. PubMed ID: 30413563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status and costs of smoking cessation in countries of the Eastern Mediterranean Region.
    Heydari G; Talischi F; Mojgani N; Masjedi MR; Algouhmani H; Lando HA; Ahmady EA
    East Mediterr Health J; 2012 Nov; 18(11):1102-6. PubMed ID: 23301371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
    Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J
    Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
    French KM; Gonzalez SZ; Sherman SE; Link AR; Malik SZ; Tseng CH; Jumkhawala SA; Tejada B; White A; Ladapo JA
    Trials; 2018 Nov; 19(1):646. PubMed ID: 30463608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM; Lyseng-Williamson KA
    Pharmacoeconomics; 2010; 28(3):231-54. PubMed ID: 20108995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The total lifetime health cost savings of smoking cessation to society.
    Rasmussen SR; Prescott E; Sørensen TI; Søgaard J
    Eur J Public Health; 2005 Dec; 15(6):601-6. PubMed ID: 16014659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of smoking cessation to prevent operative complications following elective abdominal colon surgery.
    Kulaylat AS; Hollenbeak CS; Soybel DI
    Am J Surg; 2018 Dec; 216(6):1082-1089. PubMed ID: 30262122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health policy interventions: the pathway to public health].
    Andersen K; Gudnason V
    Laeknabladid; 2013 Mar; 99(3):129-34. PubMed ID: 23486685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
    Essex HN; Parrott S; Wu Q; Li J; Cooper S; Coleman T
    Nicotine Tob Res; 2015 Jun; 17(6):636-42. PubMed ID: 25481916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in health care costs before and after smoking cessation.
    Fishman PA; Thompson EE; Merikle E; Curry SJ
    Nicotine Tob Res; 2006 Jun; 8(3):393-401. PubMed ID: 16801297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M; Raymond V; Paradis PE
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.